pleasure
| 4:50PM 11/16/2009
Not two months after the Swiss start-up Cytos's experimental anti-smoking vaccine failed in a mid-stage study, Nabi Biopharmaceuticals (NABI) and GlaxoSmithKline (GSK) have signed a licensing agreement for Nabi's own anti-smoking vaccine, NicVAX. The deal, which could potentially be worth more than...
| 1:00PM 5/19/2009
The double entendre is so thick, it's triple. A threesome? You see, we can't help ourselves. Because Mars' new "Fling" -- the first new chocolate bar the company has introduced in 20 years -- is just dripping with sexual innuendo. What's a word more in-your-face than "innuendo"? Outuendo? The...
| 1:00PM 9/17/2008
Despite the economic crunch and indicators that business travel was slowing, Orbitz for Business reported today in its quarterly report that almost two thirds of business travelers are traveling as much or more than they have in past years, an increase over last quarter. The survey also picked up...